RocketLab Q2 FY12/24 Earnings Review

DISCLAIMER: This note is intended for US recipients only and, in particular, is not directed at, nor intended to be relied upon by any UK recipients. Any information or analysis in this note is not an offer to sell or the solicitation of an offer to buy any securities. Nothing in this note is intended to be investment advice and nor should it be relied upon to make investment decisions. Cestrian Capital Research, Inc., its employees, agents or affiliates, including the author of this note, or related persons, may have a position in any stocks, security, or financial instrument referenced in this note. Any opinions, analyses, or probabilities expressed in this note are those of the author as of the note's date of publication and are subject to change without notice. Companies referenced in this note or their employees or affiliates may be customers of Cestrian Capital Research, Inc. Cestrian Capital Research, Inc. values both its independence and transparency and does not believe that this presents a material potential conflict of interest or impacts the content of its research or publications.

Still In The Ascent, No Pad Fire Yet

by Alex King, CEO, Cestrian Capital Research, Inc.

RocketLab would, in previous eras of capital markets, be a venture capital-backed business that one day hoped to go public. Or it would have been sold to SpaceX for a song in the event it ran out of money. But thanks to the post-Covid free money SPAC era, your ageing uncle and his dog can buy $RKLB with the remainder of his dwindling life savings, and no-one can stop him from doing so.

The company is in reasonable shape; contract wins are growing, the product base expanding, the balance sheet remains viable, revenue is going up, cash burn is going down, etc.

The stock remains highly speculative and should, in my view, be treated as such.

So, let's get to work on RKLB Q2.